Literature DB >> 3749998

Continuous passive motion after total knee arthroplasty.

T H Goletz, J H Henry.   

Abstract

We established a clinical retrospective study to determine the benefit of continuous passive motion after total knee replacement. Nineteen patients who had continuous passive motion (CPM) after total knee replacement were compared to a control group of 15 patients who did not have CPM. The number of days to discharge was 16 for the CPM group and 20 for the control group. When the patients with complications from CPM were excluded from the CPM group, the average number of days to discharge for the CPM group was 12. The average number of postoperative days before reaching 90 degrees of knee flexion was nine in the CPM group as compared to 16 days in the control group. The average blood loss was not significantly different in the two groups. There were four wound healing complications in the CPM group. All four complications occurred in patients who achieved 90 degrees of knee flexion in less than six days postoperatively. We developed a protocol for maximal use of CPM without significant wound complications after total knee surgery.

Entities:  

Mesh:

Year:  1986        PMID: 3749998     DOI: 10.1097/00007611-198609000-00019

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  Beneficial effects of continuous passive motion after total condylar knee arthroplasty.

Authors:  D P Johnson; D M Eastwood
Journal:  Ann R Coll Surg Engl       Date:  1992-11       Impact factor: 1.891

2.  Continuous passive motion following total knee replacement: a prospective randomized trial with follow-up to 1 year.

Authors:  W Leach; J Reid; F Murphy
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2006-02-18       Impact factor: 4.342

3.  Continuous passive motion not affect the knee motion and the surgical wound aspect after total knee arthroplasty.

Authors:  Sergi Gil-González; Ricardo Andrés Barja-Rodríguez; Antoni López-Pujol; Hussein Berjaoui; Jose Enrique Fernández-Bengoa; Juan Ignacio Erquicia; Joan Leal-Blanquet; Xavier Pelfort
Journal:  J Orthop Surg Res       Date:  2022-01-15       Impact factor: 2.359

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.